Article Versions Notes

Mancuso R, Citterio LA, Agostini S, Marventano I, La Rosa F, Re F, Seneci P, Saresella M, Clerici M. Glibenclamide-Loaded Nanoparticles Reduce NLRP3 Inflammasome Activation and Modulate miR-223-3p/miR-7-1-5p Expression in THP-1 Cells. Pharmaceuticals. 2023; 16(11):1590. https://doi.org/10.3390/ph16111590

Mancuso, Roberta, Lorenzo Agostino Citterio, Simone Agostini, Ivana Marventano, Francesca La Rosa, Francesca Re, Pierfausto Seneci, Marina Saresella, and Mario Clerici. 2023. "Glibenclamide-Loaded Nanoparticles Reduce NLRP3 Inflammasome Activation and Modulate miR-223-3p/miR-7-1-5p Expression in THP-1 Cells" Pharmaceuticals 16, no. 11: 1590. https://doi.org/10.3390/ph16111590

Mancuso, R., Citterio, L. A., Agostini, S., Marventano, I., La Rosa, F., Re, F., Seneci, P., Saresella, M., & Clerici, M. (2023). Glibenclamide-Loaded Nanoparticles Reduce NLRP3 Inflammasome Activation and Modulate miR-223-3p/miR-7-1-5p Expression in THP-1 Cells. Pharmaceuticals, 16(11), 1590. https://doi.org/10.3390/ph16111590